The South and Central America cancer vaccines market was valued at US$ 191.89 million in 2019 and is projected to reach US$ 627.49 million by 2027; it is expected to grow at a CAGR of 16.3% during the forecast period.
The growth of the South & Central America Cancer Vaccines market is mainly attributed to the growing prevalence of cancer andinitiatives taken by global health organization.Cancer is one of the primary epidemic diseases, and the number of people with cancer has become over double the number in the past three decades. According to data of an article, RevistaBrasileira de Cancerologia 2018, during 2018-2019, there would be approximately 600,000 new cases of cancer.
Brazil Cancer Vaccines Market Revenue and Forecast to 2027 (US$ Million)
SOUTH & CENTRAL AMERICA CANCER VACCINES – MARKET SEGMENTATION
By Technology
- Dendritic Cells Cancer Vaccines
- Recombinant Cancer Vaccines
- Antigen Cancer Vaccines
- Whole Cell Cancer Vaccines
- Viral Vector Cancer Vaccines
By Type
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccine
By Indication
- Cervical Cancer
- Prostate Cancer
- Other Indications
By End Use
- Pediatrics
- Adults
By Country
- Brazil
- Argentina
- RoSCAM
CompanyProfiles
- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom
South and Central America Cancer Vaccines Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 191.89 Million |
| Market Size by 2027 | US$ 627.49 Million |
| Global CAGR (2019 - 2027) | 16.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Type, Indication, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Brazil, Argentina
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - South and Central America Cancer Vaccines Market
- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom
Get Free Sample For